GRACELL BIOTECHNOLOGIES INC shareholders Q3 2023

GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 46 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

GRACELL BIOTECHNOLOGIES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vivo Capital, LLC 10,881,144$31,337,6953.43%
Sio Capital Management, LLC 2,081,216$5,993,9021.86%
Pivotal bioVenture Partners Investment Advisor LLC 1,375,000$3,960,0001.58%
TCG Crossover Management, LLC 3,038,889$8,752,0001.29%
Logos Global Management LP 2,525,000$7,272,0000.97%
SPHERA FUNDS MANAGEMENT LTD. 1,531,497$4,410,7110.80%
Orbimed Advisors 9,308,726$26,809,1310.57%
GREAT POINT PARTNERS LLC 579,667$1,669,4410.30%
Temasek Holdings (Private) Ltd 9,901,940$28,517,5870.17%
TANG CAPITAL MANAGEMENT LLC 159,087$458,1710.06%
DeepCurrents Investment Group LLC 275,000$792,0000.03%
Schonfeld Strategic Advisors LLC 759,393$2,187,0510.02%
Baker Brothers Advisors 1,000,000$2,880,0000.02%
LMR Partners LLP 484,516$873,5050.01%
Hudson Bay Capital Management LP 4,000,000$2,257,9200.01%
ADAGE CAPITAL PARTNERS GP, L.L.C. 850,000$2,448,0000.01%
Verition Fund Management LLC 86,644$249,5350.00%
PRELUDE CAPITAL MANAGEMENT, LLC 16,327$47,0220.00%
Tower Research Capital LLC (TRC) 34,434$99,1700.00%
Bellevue Group AG 38,000$109,4400.00%
External links

This page lists GRACELL BIOTECHNOLOGIES INC's shareholders in Q3 2023. To view GRACELL BIOTECHNOLOGIES INC's shareholder history, click here.